No abstract available
MeSH terms
-
Biosimilar Pharmaceuticals / adverse effects
-
Biosimilar Pharmaceuticals / economics
-
Biosimilar Pharmaceuticals / therapeutic use*
-
Drug Approval
-
Drug Costs / trends
-
Drug Substitution / trends
-
Drug Utilization / trends
-
European Union
-
Filgrastim / adverse effects
-
Filgrastim / economics
-
Filgrastim / therapeutic use*
-
Hematologic Agents / adverse effects
-
Hematologic Agents / economics
-
Hematologic Agents / therapeutic use*
-
Humans
-
Japan
-
Practice Patterns, Physicians' / economics
-
Practice Patterns, Physicians' / trends*
-
United States
Substances
-
Biosimilar Pharmaceuticals
-
Hematologic Agents
-
Filgrastim